Efficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Progress Following First-line Therapy

Press/Media: Press / Media

Period2018 Oct 2

Media coverage

1

Media coverage

  • TitleEfficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Progress Following First-line Therapy
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date18/10/2
    PersonsYong Soo Cho